US Bancorp’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.4K Buy
5,670
+670
+13% +$2.9K ﹤0.01% 3171
2025
Q4
$17.8K Sell
5,000
-479
-9% -$2.94K ﹤0.01% 3124
2025
Q3
$48.8K Sell
5,479
-733
-12% -$7.43K ﹤0.01% 2686
2025
Q2
$57.3K Buy
6,212
+687
+12% +$5.87K ﹤0.01% 2709
2025
Q1
$47.4K Sell
5,525
-147
-3% -$1.39K ﹤0.01% 2773
2024
Q4
$60.9K Buy
5,672
+29
+0.5% +$223 ﹤0.01% 2651
2024
Q3
$32.1K Buy
5,643
+479
+9% +$2.76K ﹤0.01% 2946
2024
Q2
$21.8K Sell
5,164
-311
-6% -$1.26K ﹤0.01% 3034
2024
Q1
$27.9K Buy
5,475
+52
+1% +$293 ﹤0.01% 2956
2023
Q4
$50.5K Buy
5,423
+259
+5% +$1.78K ﹤0.01% 2671
2023
Q3
$33.8K Buy
5,164
+4,907
+1,909% +$39.1K ﹤0.01% 2628
2023
Q2
$2.09K Sell
257
-607
-70% -$5.2K ﹤0.01% 3679
2023
Q1
$7.4K Buy
864
+658
+319% +$6.57K ﹤0.01% 3392
2022
Q4
$1.91K Buy
206
+42
+26% +$449 ﹤0.01% 3787
2022
Q3
$2K Hold
164
﹤0.01% 3799
2022
Q2
$2K Buy
+164
New +$1.55K ﹤0.01% 3794
2022
Q1
Sell
-505
Closed -$9K 4059
2021
Q4
$9K Buy
505
+478
+1,770% +$9.08K ﹤0.01% 3448
2021
Q3
$0 Buy
+27
New +$537 ﹤0.01% 4071

Other funds holding AVXL